- Investing Ideas
- Belgian Pharmaceuticals & Biotech Price disconnect
Belgian Pharmaceuticals & Biotech Price disconnect
Results
2
0 new
Stocks which the market has priced substantially different to their cash flows, which could imply risk.
2 companies
argenx
Market Cap: €51.7b
A commercial-stage biopharma company, develops various therapies for the treatment of autoimmune diseases in the United States, Japan, China, the Netherlands, and internationally.
ARGX
€830.80
7D
5.9%
1Y
77.9%
UCB
Market Cap: €49.4b
A biopharmaceutical company, develops products and solutions for people with neurology and immunology diseases worldwide.
UCB
€259.50
7D
0.4%
1Y
53.6%